Pneumovax 23
Payments companies reported to CMS as associated with Pneumovax 23. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Pneumovax 23, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Pneumovax 23
These are the largest totals companies reported as associated with Pneumovax 23. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Gerardo Tosca | San Juan, PR | Pediatrics | $2,250.00 |
| Diego Sanz De La Pena | San Juan, PR | Pediatrics | $2,250.00 |
| Paul Hunter | Madison, WI | Family Medicine | $1,513.13 |
| Emily Messerli | Lexington, KY | Family | $1,504.74 |
| Luis Garcia Barreto | Coamo, PR | Pulmonary Disease | $1,500.00 |
| Henry Diaz | Coamo, PR | Cardiovascular Disease | $1,500.00 |
| Giovanni Veloz Irizarry | Ponce, PR | Pulmonary Disease | $1,500.00 |
| Luis Gely | Caguas, PR | Cardiovascular Disease | $1,500.00 |
| Alvaro Aranda Rodriguez | Guaynabo, PR | Pulmonary Disease | $1,500.00 |
| Rigoberto Ramos Gonzalez | Adjuntas, PR | Cardiovascular Disease | $1,500.00 |
Prescribed Pneumovax 23?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.